Table 2. Cost reductions predicted by variations of the spatial model.
Model Variant | Total | Flight | Vaccine |
---|---|---|---|
Baseline model | 22% | 4% | 18% |
0.7 herd immunity threshold | 16% | 2% | 15% |
Temporary immunity | 29% | 4% | 25% |
Clustered vaccine distribution | 22% | 5% | 16% |
Lagged immunity | 21% | 4% | 17% |
Lifelong vaccine infection | 29% | 10% | 19% |
25% Increased vaccine cost | 16% | 2% | 14% |
“Total” column shows the percent reduction in total costs that result from using a transmissible vaccine with R0,v = 1, relative a nontransmissible vaccine. “Flight” and “Vaccine” columns decompose the total reduction into savings from flight expenses, and expenses due to the purchase of vaccine baits. Percentages are rounded to the nearest whole number. The Baseline model describes a host population density of 10 km−2. Other parameters of the Baseline model are: d = 0.416 yr−1, δv = 12 yr−1, ξ = 0.25 km, Cf = 18.16 km−1, Cb = 2.12.